An update on the biology of cancer stem cells in breast cancer

Clinical and Translational Oncology

Volumn 10, Issue 12, 2008, Pages 786-793

  García Bueno, José María ^a,b   Ocaña, Alberto ^a,b   Castro García, Paola ^a   Gil Gas, Carmen ^a   Sánchez Sánchez, Francisco ^c   Poblet, Enrique ^a,b   Serrano, Rosario ^a   Calero, Raúl ^a   Ramírez Castillejo, Carmen ^a  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^b CHUA   (Spain)

^c Área de Genética Facultad de Medicina CRIB   (Spain)

Author keywords

ABC transporters; Breast cancer; Cancer; Cancer Stem Cell; Hedgehog; Notch; PEDF; Target therapies; Wnt

Indexed keywords

ANTINEOPLASTIC AGENT; TUMOR MARKER;

BIOLOGICAL MODEL; BREAST TUMOR; CANCER STEM CELL; CELL DIFFERENTIATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; ENVIRONMENT; FEMALE; GENETICS; HUMAN; METABOLISM; METHODOLOGY; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; REVIEW; SYNTHESIS;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL DIFFERENTIATION; DRUG DELIVERY SYSTEMS; DRUG DESIGN; ENVIRONMENT; FEMALE; HUMANS; MODELS, BIOLOGICAL; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; TUMOR MARKERS, BIOLOGICAL;

EID: 60549089844     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-008-0291-9     Document Type: Article

References (77)

1. Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3:730-737
2. Hamburger AW, Salmon SE (1977) Primary bioassay of human tumor stem cells. Science 197: 461-463
3. Larochelle A, Vormoor J, Hanenberg H et al (1996) Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med 2:1329-1337
4. Reynolds BA, Weiss S (1992) Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255: 1707-1710
5. Davis AA, Temple S (1994) A self-renewing multipotential stem cell in embryonic rat cerebral cortex. Nature 372:263-266
6. Temple S (2001) The development of neural stem cells. Nature 414:112-117
7. Bassin RH, Plata EJ, Gerwin BI et al (1972) Isolation of a continuous epithelioid cell line, HBT-3, from a human breast carcinoma. Proc Soc Exp Biol Med 141:673-680
8. Whitehead RH, Bertoncello I, Webber LM, Pedersen JS (1983) A new human breast carcinoma cell line (PMC42) with stem cell characteristics. I. Morphologic characterization. J Natl Cancer Inst 70:649-661
9. Beier D, Hau P, Proescholdt M et al (2007) CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67:4010-4015
10. Dalerba P, Dylla SJ, Park IK et al (2007) Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A 104:10158-10163
11. Gu G, Yuan J, Wills M, Kasper S (2007) Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res 67:4807-4815
12. Ho MM, Ng AV, Lam S, Hung JY (2007) Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 67:4827-4833
13. Wang J, Guo LP, Chen LZ et al (2007) Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res 67:3716-3724
14. Smith GH, Medina D (1988) A morphologically distinct candidate for an epithelial stem cell in mouse mammary gland. J Cell Sci 90:173-183
15. Murphy KL, Dennis AP, Rosen JM (2000) A gain of function p53 mutant promotes both genomic instability and cell survival in a novel p53-null mammary epithelial cell model. FASEB J 14: 2291-2302
16. Xu X, Wagner KU, Larson D et al (1999) Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 22:37-43
17. Al Hajj M, Wicha MS, Benito-Hernandez A et al (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100:3983-3988
18. Herman PC, Huber SL, Herrier T et al (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1:313-323
19. Weissman I (2005) Stem cell research: paths to cancer therapies and regenerative medicine. JAMA 294:1359-1366
20. Ocana A, Hortobagyi GN, Esteva FJ (2006) Concomitant versus sequential chemotherapy in the treatment of early-stage and metastatic breast cancer. Clin Breast Cancer 6:495-504
21. Hamilton A, Hortobagyi G (2005) Chemotherapy: what progress in the last 5 years? J Clin Oncol 23:1760-1775
22. Weinberg RA (2007) Using maths to tackle cancer. Nature 449:978-981
23. Marx J (2003) Cancer research. Mutant stem cells may seed cancer. Science 301:1308-1310
24. Bjerkvig R, Tysnes BB, Aboody KS et al (2005) Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer 5:899-904
25. Qian X, Shen Q, Goderie SK et al (2000) Timing of CNS cell generation: a programmed sequence of neuron and glial cell production from isolated murine cortical stem cells. Neuron 28: 69-80
26. Setoguchi T, Taga T, Kondo T (2004) Cancer stem cells persist in many cancer cell lines. Cell Cycle 3:414-415
27. Kondo T, Setoguchi T, Taga T (2004) Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci U S A 101:781-786
28. Uchida N, Buck DW, He D et al (2000) Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A 97:14720-14725
29. Toren A, Bielorai B, Jacob-Hirsch J et al (2005) CD133-positive hematopoietic stem cell "stemness" genes contain many genes mutated or abnormally expressed in leukemia. Stem Cells 23:1142-1153
30. Chiba T, Kita K, Zheng YW et al (2006) Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 44:240-251
31. Collins AT, Berry PA, Hyde C et al (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65:10946-10951
32. Miki J, Furusato B, Li H et al (2007) Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res 67:3153-3161
33. Singh SK, Clarke ID, Terasaki M et al (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821-5828
34. Yuan X, Curtin J, Xiong Y et al (2004) Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23:9392-9400
35. Liu G, Yuan X, Zeng Z et al (2006) Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 5: 67
36. Florek M, Haase M, Marzesco AM et al (2005) Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tissue Res 319:15-26
37. O'Brien CA, Pollett A, Gallinger S, Dick JE (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106-110
38. Ricci-Vitiani L, Lombardi DG, Pilozzi E et al (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445:111-115
39. Barker N, van Es JH, Kuipers J et al (2007) Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449:1003-1007
40. Ponti D, Zaffaroni N, Capelli C, Daidone MG (2006) Breast cancer stem cells: an overview. Eur J Cancer 42:1219-1224
41. Clarke RB, Spence K, Anderson E et al (2005) A putative human breast stem cell population is enriched for steroid receptor-positive cells. Dev Biol 277:443-456
42. Dalerba P, Cho RW, Clarke MF (2007) Cancer stem cells: models and concepts. Annu Rev Med 58:267-284
43. Feinberg AP, Ohlsson R, Henikoff S (2006) The epigenetic progenitor origin of human cancer. Nat Rev Genet 7:21-33
44. Brabletz T, Jung A, Spaderna S et al (2005) Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer 5:744-749
45. Thiery JP (2003) Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15:740-746
46. Balic M, Lin H, Young L et al (2006) Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res 12:5615-5621
47. Orimo A, Gupta PB, Sgroi DC et al (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121:335-348
48. Liu R, Wang X, Chen GY et al (2007) The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 356:217-226
49. Massague J (2007) Sorting out breast-cancer gene signatures. N Engl J Med 356:294-297
50. Folkins C, Man S, Xu P et al (2007) Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors. Cancer Res 67:3560-3564
51. Chang A, Li X, Wong H (2007) Therapeutic resistance and tumor-initiation: molecular pathways involved in breast cancer stem cell self-renewal. J Clin Oncol 25:528
52. Jiffar T, Kurinna S, Suck G et al (2004) PKC alpha mediates chemoresistance in acute lymphoblastic leukemia through effects on Bcl2 phosphorylation. Leukemia 18:505-512
53. Szakacs G, Annereau JP, Lababidi S et al (2004) Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. Cancer Cell 6:129-137
54. Hirschmann-Jax C, Foster AE, Wulf GG et al (2004) A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A 101:14228-14233
55. Phillips TM, McBride WH, Pajonk F (2006) The response of CD24(-/low)/CD44+ breast cancerinitiating cells to radiation. J. Natl. Cancer Inst. 98:1777-85
56. Bao S, Wu Q, McLendon RE, et al (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756-60
57. Hynes NE, Lane HA (2005) ERBB receptors and cancer: the complexity of targeted inhibitors. Nat. Rev. Cancer 5:341-54
58. Yarden Y, Sliwkowski MX (2001) Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2:127-37
59. Massague J, Pandiella A (1993) Membrane-anchored growth factors. Annu. Rev. Biochem. 62:515-41
60. Schlessinger J (2000) Cell signaling by receptor tyrosine kinases. Cell 103:211-25
61. Doetsch F, Petreanu L, Caille I, et al (2002) EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells. Neuron 36:1021-34
62. Baselga J, Arteaga CL (2005) Critical update and emerging trends in epidermal growth factor receptor targeting in cancer. J. Clin. Oncol. 23: 2445-59
63. Jackson EL, Garcia-Verdugo JM, Gil-Perotin S, et al (2006) PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form gliomalike growths in response to increased PDGF signaling. Neuron 51:187-99
64. Shipitsin M, Campbell LL, Argani P, et al (2007) Molecular definition of breast tumor heterogeneity. Cancer Cell 11:259-73
65. Biswas S, Criswell TL, Wang SE, et al (2006) Inhibition of transforming growth factor-beta signaling in human cancer: targeting a tumor suppressor network as a therapeutic strategy. Clin. Cancer Res. 12:4142-6
66. Bruna A, Darken RS, Rojo F, et al (2007) High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell 11:147-60
67. Artavanis-Tsakonas S, Rand MD, Lake RJ (1999) Notch signaling: cell fate control and signal integration in development. Science 284:770-6
68. Bray SJ. 2006. Notch signalling: a simple pathway becomes complex. Nat. Rev. Mol. Cell Biol. 7:678-89
69. Sun Y, Lowther W, Kato K, et al (2005) Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-beta signaling. Oncogene 24:5365-74
70. Fan X, Matsui W, Khaki L, Stearns D, Chun J, Li YM, Eberhart CG. 2006. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res. 66:7445-52
71. Reya T, Clevers H (2005) Wnt signalling in stem cells and cancer. Nature 434:843-50
72. Liu S, Dontu G, Mantle ID, et al (2006) Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells 28. Cancer Res. 66:6063-71
73. Ramirez-Castillejo C, Sanchez-Sanchez F, Andreu-Agullo C, et al (200)6) Pigment epitheliumderived factor is a niche signal for neural stem cell renewal. Nat. Neurosci. 9:331-9
74. Notari L, Baladron V, Aroca-Aguilar JD et al (2006) Identification of a lipase-linked cell-membrane receptor for Pigment Epithelium-derived factor (PEDF). J. Biol. Chem. en revision
75. Gilbertson RJ, Rich JN (2007) Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat. Rev. Cancer 7:733-6
76. Miller K (2007) A randomized phase III trial of paclitaxel versus paclitaxel plus bevacizumab as first-line therapy for locally recurrent or metastatic breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group (E2100). San Antonio Breast Cancer Symposium. Abstract 3
77. Ohno-Matsui K, Morita I, Tombran-Tink J, et al (2001) Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF. J. Cell Physiol 189:323-33.